CompletedPhase 3NCT01987011

Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers

Studying Avian influenza

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Green Cross Corporation
Principal Investigator
Woo Joo Kim, MD, Ph.D
Korea University Guro Hospital
Intervention
MG1109(biological)
Enrollment
420 enrolled
Eligibility
18-60 years · All sexes
Timeline
20132014

Study locations (4)

Collaborators

Korean Center for Disease Control and Prevention

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01987011 on ClinicalTrials.gov

Other trials for Avian influenza

Additional recruiting or active studies for the same condition.

See all trials for Avian influenza

← Back to all trials